Blood test could replace invasive biopsies for prostate cancer monitoring
NCT ID NCT07478536
Summary
This study is testing whether a blood test called Stockholm3 can accurately detect when prostate cancer becomes more aggressive in men who are being monitored instead of immediately treated. The goal is to see if this test can help doctors safely follow patients with fewer invasive biopsies. The study will involve 350 men who are already on active surveillance and scheduled for routine follow-up biopsies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Inselspital, University Hospital of Bern
Bern, Canton of Bern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.